首页> 美国卫生研究院文献>The Journal of General Virology >Human papillomavirus type 16 viral load measurement as a predictor of infection clearance
【2h】

Human papillomavirus type 16 viral load measurement as a predictor of infection clearance

机译:人乳头瘤病毒16型病毒载量测量可预测感染清除率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Viral load measurements may predict whether human papillomavirus (HPV) type 16 infections may become persistent and eventually lead to cervical lesions. Today, multiple PCR methods exist to estimate viral load. We tested three protocols to investigate viral load as a predictor of HPV clearance. We measured viral load in 418 HPV16-positive cervical smears from 224 women participating in the Ludwig–McGill Cohort Study by low-stringency PCR (LS-PCR) using consensus L1 primers targeting over 40 known HPV types, and quantitative real-time PCR (qRT-PCR) targeting the HPV16 E6 and L1 genes. HPV16 clearance was determined by MY09/11 and PGMY PCR testing on repeated smears collected over 5 years. Correlation between viral load measurements by qRT-PCR (E6 versus L1) was excellent (Spearman’s rank correlation, ρ = 0.88), but decreased for L1 qRT-PCR versus LS-PCR (ρ = 0.61). Viral load by LS-PCR was higher for HPV16 and related types independently of other concurrent HPV infections. Median duration of infection was longer for smears with high copy number by all three PCR protocols (log rank P<0.05). Viral load is inversely related to HPV16 clearance independently of concurrent HPV infections and PCR protocol.
机译:病毒载量测量可以预测16型人乳头瘤病毒(HPV)感染是否可能持续存在并最终导致宫颈病变。如今,存在多种PCR方法来估算病毒载量。我们测试了三种方案以调查病毒载量作为预测HPV清除率的指标。我们采用低严格度PCR(LS-PCR)方法,使用针对40多种已知HPV类型的共有L1引物,并通过定量实时PCR( qRT-PCR)靶向HPV16 E6和L1基因。 HPV16清除率是通过MY09 / 11和PGMY PCR测试对5年以上的重复涂片进行测定的。通过qRT-PCR测量的病毒载量之间的相关性(E6与L1)非常好(Spearman等级相关性,ρ= 0.88),但是对于L1 qRT-PCR与LS-PCR而言,相关性降低(ρ= 0.61)。 LS-PCR的病毒载量对于HPV16和相关类型而言较高,独立于其他并发HPV感染。通过所有三种PCR方案,具有高拷贝数的涂片的中位感染持续时间更长(对数等级P <0.05)。病毒载量与HPV16清除率成反比,与并发HPV感染和PCR方案无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号